Literature DB >> 3305554

Human fertilization in vivo, with special reference to progression, storage and release of competent spermatozoa.

R H Hunter.   

Abstract

Whilst very large numbers of spermatozoa accumulate in the cervical mucus and crypts in the hours following coitus, evidence is offered from species with comparable gonadotrophin surge-to-ovulation intervals to suggest that the cervix is not the site of the functional sperm reservoir in women. On the contrary, human spermatozoa involved in the events of fertilization may spend the greater part of the pre-ovulatory interval in the distal portion of the Fallopian tube, that is in the intra-mural segment. This would enable spermatozoa to be arrested within reach of the site of fertilization in the ampullary region of the tube, and to be activated and released close to the time of ovulation by means of a local transfer of high concentrations of ovarian follicular hormones. The clinical importance of confirming this proposed role for the intra-mural segment of the tube is stressed, as is the possibility of specific micro-environments within the lumen of the duct.

Entities:  

Mesh:

Year:  1987        PMID: 3305554     DOI: 10.1093/oxfordjournals.humrep.a136544

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  3 in total

1.  Sperm attraction to a follicular factor(s) correlates with human egg fertilizability.

Authors:  D Ralt; M Goldenberg; P Fetterolf; D Thompson; J Dor; S Mashiach; D L Garbers; M Eisenbach
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

2.  In vivo survival of spermatozoa in the human fallopian tube for 25 days: a case report.

Authors:  R T Mansour; M A Aboulghar; G I Serour; A M Abbas; A M Ramzy; B Rizk
Journal:  J Assist Reprod Genet       Date:  1993-07       Impact factor: 3.412

3.  Odorant receptors and desensitization proteins colocalize in mammalian sperm.

Authors:  L D Walensky; A J Roskams; R J Lefkowitz; S H Snyder; G V Ronnett
Journal:  Mol Med       Date:  1995-01       Impact factor: 6.354

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.